Savitz Ryan Insider Trading -- Recent SEC Form 4 Transactions
Savitz Ryan (CIK 1992324) reported 39 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-11-12). Recent activity: Buy DNTH (29,276 shares), Sell DNTH (17,724 shares), Buy DNTH (40,430 shares), Buy DNTH (10,399 shares), Sell DNTH (300 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-11-12 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | EVP, CFO & CBO | Buy | 29,276 | $523,455 |
| 2026-11-12 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | EVP, CFO & CBO | Sell | 17,724 | $1.6M |
| 2026-11-12 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | EVP, CFO & CBO | Buy | 40,430 | $892,290 |
| 2026-11-12 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | EVP, CFO & CBO | Buy | 10,399 | $87,768 |
| 2026-11-12 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | EVP, CFO & CBO | Sell | 300 | $25,548 |
| 2026-11-12 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | EVP, CFO & CBO | Sell | 700 | $60,690 |
| 2026-11-12 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | EVP, CFO & CBO | Sell | 1,736 | $154,226 |
| 2026-11-12 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | EVP, CFO & CBO | Buy | 20,608 | $448,636 |
| 2026-11-12 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | EVP, CFO & CBO | Sell | 58,396 | $5.3M |
| 2026-11-12 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | EVP, CFO & CBO | Sell | 2,064 | $189,042 |
| 2026-11-12 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | EVP, CFO & CBO | Buy | 1,301 | $28,323 |
| 2026-11-12 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | EVP, CFO & CBO | Buy | 1,260 | $27,808 |
| 2026-11-12 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | EVP, CFO & CBO | Sell | 2,561 | $230,849 |
| 2026-11-12 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | EVP, CFO & CBO | Buy | 1,744 | $37,967 |
| 2026-11-12 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | EVP, CFO & CBO | Buy | 1,300 | $28,691 |
| 2026-11-12 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | EVP, CFO & CBO | Sell | 3,044 | $274,051 |
| 2026-11-12 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | EVP, CFO & CBO | Buy | 1,339 | $29,150 |
| 2026-11-12 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | EVP, CFO & CBO | Buy | 16,385 | $361,617 |
| 2026-11-12 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | EVP, CFO & CBO | Sell | 37,517 | $3.4M |
| 2026-07-13 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | EVP, CFO & CBO | Sell | 10,354 | $1.0M |
| 2026-07-13 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | EVP, CFO & CBO | Sell | 15,329 | $1.6M |
| 2026-07-13 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | EVP, CFO & CBO | Sell | 5,566 | $567,565 |
| 2026-07-13 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | EVP, CFO & CBO | Buy | 31,249 | $680,291 |
| 2026-04-10 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | EVP, CFO & CBO | Sell | 8,224 | $738,844 |
| 2026-04-10 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | EVP, CFO & CBO | Buy | 8,224 | $147,045 |
Source: SEC Form 4 filings · as of 2026-11-12